WELLACY Trademark

Trademark Overview

On Tuesday, August 23, 2022, a trademark application was filed for WELLACY with the United States Patent and Trademark Office. The USPTO has given the WELLACY trademark a serial number of 97560119. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by Medlab Diagnostics LLC. The WELLACY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for providing clinician oversight to the direct-to-patient laboratory industry
wellacy

General Information

Serial Number97560119
Word MarkWELLACY
Filing DateTuesday, August 23, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements

Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for providing clinician oversight to the direct-to-patient laboratory industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedlab Diagnostics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSt. Petersburg, FL 33702
Party NameMedlab Diagnostics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Petersburg, FL 33702

Trademark Events

Event DateEvent Description
Monday, September 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 9, 2023ASSIGNED TO EXAMINER
Monday, June 12, 2023NON-FINAL ACTION WRITTEN
Monday, June 12, 2023NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023FINAL REFUSAL WRITTEN
Thursday, July 20, 2023FINAL REFUSAL E-MAILED
Thursday, July 20, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 20, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, October 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 23, 2024SOU EXTENSION 1 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION

Related Keywords

wellacy oversight clinician direct patient industry laboratory providing platforms paas service